Download PDF
Thromb Haemost 2000; 84(06): 1120-1121
DOI: 10.1055/s-0037-1614182
Letters to the Editor
Schattauer GmbH

Functional Determination of Soluble Fibrin Polymers (SFP) in Plasma

Thomas W. Stief
1   From the Institute of Clinical Chemistry and Molecular Diagnostics, University Hospital of Philipps University, Marburg, Germany
› Author Affiliations
Further Information

Publication History

Received 17 January 2000

Accepted after resubmission 24 July 2000

Publication Date:
13 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 McCarron BI, Marder VJ, Francis CW. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy. Thromb Haemost 1999; 82: 1722-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Wiman B, Ranby M. Determination of soluble fibrin in plasma by a rapid and quantitative spectrophotometric assay. Thromb Haemost 1986; 55: 189-93.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Bredbacka S, Blombäck M, Wiman B. Soluble fibrin: a predictor for the development and outcome of multiple organ failure. Am J Hematol 1994; 46: 289-94.
    CrossrefPubMedGoogle Scholar
  • 4 Lee LV, Ewald GA, McKenzie CR, Eisenberg PR. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction. Arterioscler Thromb Vasc Biol 1997; 17: 628-33.
    CrossrefPubMedGoogle Scholar
  • 5 Laurino JP, Pelletier TE, Eadry R, Kounavis A. Thrombus Precursor Protein and the measurement of thrombosis in patients with acute chest pain syndrome. Ann Clin Lab Sci 1997; 27: 338-45.
    PubMedGoogle Scholar
  • 6 Ostlund E, Bremme K, Wiman B. Soluble fibrin in plasma as a sign of activated coagulation in patients with pregnancy complications. Acta Obstet Gynecol Scand 1998; 77: 165-9.
    CrossrefPubMedGoogle Scholar
  • 7 Suenson E, Bjerrum P, Holm A, Lind B, Meldal M, Selmer J, Petersen LC. The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation. J Biol Chem 1990; 265: 22228-37.
    CrossrefPubMedGoogle Scholar
  • 8 Stief TW. The blood fibrinolysis/deep-sea analogy: a hypothesis on singlet oxygen/photons as natural antithrombotics. Thromb Res 2000; 99: 1-20.
    CrossrefPubMedGoogle Scholar
  • 9 Stief TW, Lenz P, Becker U. A simple method for producing degradation products of fibrinogen by an insoluble derivative of plasmin. Thromb Res 1987; 48: 603-9.
    CrossrefPubMedGoogle Scholar
  • 10 Dempfle CE, Kontny F, Abildgaard U. Predictive value of coagulation markers concerning clinical outcome 90 days after anterior myocardial infarction. Thromb Haemost 1999; 81: 701-4.
    Article in Thieme ConnectPubMedGoogle Scholar